Evidence map›Paper›PMID 34562904›Full record

ArticleBiosensors2021

Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to Study the Interaction of 3D Tumor Spheroids with Cellular Barriers.

Arya Lekshmi Nair, Lena Mesch, Ingo Schulz, Holger Becker, Julia Raible, Heiko Kiessling, Simon Werner, Ulrich Rothbauer, Christian Schmees, Marius Busche and 3 more

Abstract read
In one paragraph

Article in Biosensors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Arya Lekshmi NairNMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.ORCID 0000-0002-8981-4283
Lena MeschInstitut für Neuroanatomie und Entwicklungsbiologie, University of Tübingen, Österbergstraße 3, 72074 Tübingen, Germany.
Ingo SchulzMicrofluidic ChipShop GmbH, Stockholmer Str. 20, D-07747 Jena, Germany.
Holger BeckerMicrofluidic ChipShop GmbH, Stockholmer Str. 20, D-07747 Jena, Germany.ORCID 0000-0002-7678-2518
Julia RaibleNMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.
Heiko KiesslingNMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.
Simon WernerNMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.
Ulrich RothbauerNMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.ORCID 0000-0001-5923-8986
Christian SchmeesNMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.ORCID 0000-0003-4883-2642
Marius BuscheNMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.
Sebastian TrennheuserInstitute of Pharmacy, Pharmaceutical Biotechnology, Auf der Morgenstelle 8, D-72076 Tübingen, Germany.
Gert FrickerInstitute of Pharmacy, Pharmaceutical Biotechnology, Auf der Morgenstelle 8, D-72076 Tübingen, Germany.
Martin StelzleNMI Natural and Medical Sciences Institute, University of Tübingen, Markwiesenstraße 55, 72770 Reutlingen, Germany.ORCID 0000-0003-2612-2359

Funding

Bundesministerium für Bildung und Forschung 16SV5952State Ministry of Baden-Wuerttemberg for Economic Affairs, Labour and Tourism n.a.
6 · The paper itself

Abstract

Endothelial and epithelial cellular barriers play a vital role in the selective transport of solutes and other molecules. The properties and function of these barriers are often affected in case of inflammation and disease. Modelling cellular barriers in vitro can greatly facilitate studies of inflammation, disease mechanisms and progression, and in addition, can be exploited for drug screening and discovery. Here, we report on a parallelizable microfluidic platform in a multiwell plate format with ten independent cell culture chambers to support the modelling of cellular barriers co-cultured with 3D tumor spheroids. The microfluidic platform was fabricated by microinjection molding. Electrodes integrated into the chip in combination with a FT-impedance measurement system enabled transepithelial/transendothelial electrical resistance (TEER) measurements to rapidly assess real-time barrier tightness. The fluidic layout supports the tubeless and parallelized operation of up to ten distinct cultures under continuous unidirectional flow/perfusion. The capabilities of the system were demonstrated with a co-culture of 3D tumor spheroids and cellular barriers showing the growth and interaction of HT29 spheroids with a cellular barrier of MDCK cells.

Indexed as

Microfluidic Analytical TechniquesCell Culture TechniquesDrug Evaluation, PreclinicalElectric ImpedanceElectrodesEpithelial CellsHumansMicrofluidicsNeoplasmscellular barriersFourier-transform impedance spectroscopymicrofluidic deviceTEERtumor spheroids

Identifiers

PMID34562904
PMCPMC8471981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.